Epigenetics & Chromatin

Ian Kavanagh has extensive experience in the development of molecular diagnostics with a proven track record of product launches for assays, instruments and software from companies, such as QIAGEN, Roche Diagnostics and Thermo Fisher Scientifi c. As the Chief Operating Offi cer of the newly formed APIS Assay Technologies, in Manchester, UK, he is committed to realize the clinical potential of systems biology and medicine in the diagnosis and personalization of treatment. At APIS we seek to develop biomarkers that deliver signifi cant improvements in the prediction and prevention of disease.